Successful alpha testing of Biofidelity's ASPYRE-Lung reagents demonstrates breakthrough capabilities and ease of use
September 14, 2021 04:00 ET
|
Biofidelity Limited
ASPYRE-Lung panel set up and multiple samples analyzed in US & UK test labs in as little as one day Consistent performance demonstrated across test sites and genetic variants CAMBRIDGE, United...
Biofidelity opens US headquarters and new cancer diagnostic laboratory
July 28, 2021 07:00 ET
|
Biofidelity Limited
CAMBRIDGE, United Kingdom., July 28, 2021 (GLOBE NEWSWIRE) -- Biofidelity Ltd, the cancer diagnostics company, today announces the opening of its US headquarters in Research Triangle Park, North...
Biofidelity Announces Formation of Scientific Advisory Board
July 15, 2021 05:18 ET
|
Biofidelity Limited
CAMBRIDGE, United Kingdom, July 15, 2021 (GLOBE NEWSWIRE) -- Biofidelity Ltd, the cancer diagnostics company, today announces the members of its newly-formed Scientific Advisory Board (SAB) with the...
Biofidelity granted key patent in US for breakthrough cancer diagnostic technology
April 07, 2021 04:00 ET
|
Biofidelity Limited
CAMBRIDGE, United Kingdom, April 07, 2021 (GLOBE NEWSWIRE) -- Biofidelity Ltd, the cancer diagnostics company, today announced that it has been granted a key patent in the US protecting its...
Biofidelity announces first peer reviewed publication of breakthrough ASPYRE™ technology
March 23, 2021 05:00 ET
|
Biofidelity Limited
CAMBRIDGE, United Kingdom, March 23, 2021 (GLOBE NEWSWIRE) -- Biofidelity Ltd, the cancer diagnostics company, today announces that the first peer review article detailing its novel...
Biofidelity appoints Wendy J. Levin MD MS as Chief Medical Officer
January 28, 2021 04:00 ET
|
Biofidelity Limited
Experienced US-based medical oncologist joins Biofidelity prior to launch of first diagnostic product US-trained oncologist & hematologist with over 15 years industry experience in...
Biofidelity appoints Robert Osborne as Chief Operating Officer
December 10, 2020 04:26 ET
|
Biofidelity Limited
CAMBRIDGE, United Kingdom, Dec. 10, 2020 (GLOBE NEWSWIRE) -- Biofidelity Ltd, the cancer diagnostics company, today announces the further expansion of its leadership team with the appointment of Dr....
Biofidelity opens new headquarters as part of significant expansion and drive to commercialization
December 01, 2020 04:00 ET
|
Biofidelity Limited
CAMBRIDGE, United Kingdom, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Biofidelity Ltd, the cancer diagnostics company, today announced the opening of its new headquarters as it continues its significant...
Biofidelity appoints Stephen Miller as Chief Commercial Officer
September 17, 2020 04:01 ET
|
Biofidelity Limited
US diagnostics executive with more than 25 years of industry commercial experienceSignificant commercial technology and diagnostic product launch expertiseTrack record of successful high-multiple...
Biofidelity appoints Dr. Heiner Dreismann as Chairman
September 10, 2020 05:10 ET
|
Biofidelity Limited
Veteran Roche executive with more than 35 years of industry experiencePioneer in the early adoption of polymerase chain reaction (PCR) technologyAppointment follows completion of $12 million Series A...